PMC:7306567 / 4403-4763 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"67","span":{"begin":118,"end":122},"obj":"Disease"},{"id":"68","span":{"begin":130,"end":149},"obj":"Disease"},{"id":"69","span":{"begin":247,"end":249},"obj":"Disease"},{"id":"70","span":{"begin":269,"end":271},"obj":"Disease"}],"attributes":[{"id":"A67","pred":"tao:has_database_id","subj":"67","obj":"OMIM:102510"},{"id":"A68","pred":"tao:has_database_id","subj":"68","obj":"MESH:D003141"},{"id":"A69","pred":"tao:has_database_id","subj":"69","obj":"MESH:D010300"},{"id":"A70","pred":"tao:has_database_id","subj":"70","obj":"MESH:C535509"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"To ensure heterogenicity, participants were selected from various fields of expertise: medical microbiology (PEV, KL, CL-F, TRR), infectious diseases (BJAR, MB, TC, CJC, OAC, DRG, NAFJ, BJK, OL, MH-N, TFP, FLvdV), intensive care medicine (EA, SB, PD, PW-LL, IM-L, JAS, LV, JW), clinical pharmacology (RJMB, RL, IS), public health (TC) and hematology (OAC, JM)."}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T36","span":{"begin":130,"end":140},"obj":"Disease"}],"attributes":[{"id":"A36","pred":"mondo_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"To ensure heterogenicity, participants were selected from various fields of expertise: medical microbiology (PEV, KL, CL-F, TRR), infectious diseases (BJAR, MB, TC, CJC, OAC, DRG, NAFJ, BJK, OL, MH-N, TFP, FLvdV), intensive care medicine (EA, SB, PD, PW-LL, IM-L, JAS, LV, JW), clinical pharmacology (RJMB, RL, IS), public health (TC) and hematology (OAC, JM)."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T25","span":{"begin":66,"end":72},"obj":"http://purl.obolibrary.org/obo/UBERON_0007688"},{"id":"T26","span":{"begin":118,"end":120},"obj":"http://purl.obolibrary.org/obo/CLO_0052906"},{"id":"T27","span":{"begin":157,"end":159},"obj":"http://purl.obolibrary.org/obo/PR_000010213"},{"id":"T28","span":{"begin":195,"end":197},"obj":"http://purl.obolibrary.org/obo/CLO_0007706"},{"id":"T29","span":{"begin":258,"end":260},"obj":"http://purl.obolibrary.org/obo/UBERON_0003064"},{"id":"T30","span":{"begin":307,"end":309},"obj":"http://purl.obolibrary.org/obo/CLO_0008828"},{"id":"T31","span":{"begin":356,"end":358},"obj":"http://purl.obolibrary.org/obo/CLO_0007029"},{"id":"T32","span":{"begin":356,"end":358},"obj":"http://purl.obolibrary.org/obo/CLO_0050993"}],"text":"To ensure heterogenicity, participants were selected from various fields of expertise: medical microbiology (PEV, KL, CL-F, TRR), infectious diseases (BJAR, MB, TC, CJC, OAC, DRG, NAFJ, BJK, OL, MH-N, TFP, FLvdV), intensive care medicine (EA, SB, PD, PW-LL, IM-L, JAS, LV, JW), clinical pharmacology (RJMB, RL, IS), public health (TC) and hematology (OAC, JM)."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T18","span":{"begin":114,"end":116},"obj":"Chemical"},{"id":"T19","span":{"begin":195,"end":197},"obj":"Chemical"},{"id":"T20","span":{"begin":229,"end":237},"obj":"Chemical"},{"id":"T21","span":{"begin":239,"end":241},"obj":"Chemical"},{"id":"T22","span":{"begin":247,"end":249},"obj":"Chemical"},{"id":"T23","span":{"begin":251,"end":253},"obj":"Chemical"},{"id":"T24","span":{"begin":254,"end":256},"obj":"Chemical"},{"id":"T25","span":{"begin":258,"end":260},"obj":"Chemical"},{"id":"T26","span":{"begin":269,"end":271},"obj":"Chemical"},{"id":"T27","span":{"begin":307,"end":309},"obj":"Chemical"},{"id":"T28","span":{"begin":356,"end":358},"obj":"Chemical"}],"attributes":[{"id":"A18","pred":"chebi_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/CHEBI_74561"},{"id":"A19","pred":"chebi_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/CHEBI_74703"},{"id":"A20","pred":"chebi_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A21","pred":"chebi_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/CHEBI_73849"},{"id":"A22","pred":"chebi_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/CHEBI_74756"},{"id":"A23","pred":"chebi_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/CHEBI_74797"},{"id":"A24","pred":"chebi_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/CHEBI_73531"},{"id":"A25","pred":"chebi_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/CHEBI_74073"},{"id":"A26","pred":"chebi_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/CHEBI_73579"},{"id":"A27","pred":"chebi_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/CHEBI_73815"},{"id":"A28","pred":"chebi_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/CHEBI_31739"}],"text":"To ensure heterogenicity, participants were selected from various fields of expertise: medical microbiology (PEV, KL, CL-F, TRR), infectious diseases (BJAR, MB, TC, CJC, OAC, DRG, NAFJ, BJK, OL, MH-N, TFP, FLvdV), intensive care medicine (EA, SB, PD, PW-LL, IM-L, JAS, LV, JW), clinical pharmacology (RJMB, RL, IS), public health (TC) and hematology (OAC, JM)."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T30","span":{"begin":0,"end":360},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"To ensure heterogenicity, participants were selected from various fields of expertise: medical microbiology (PEV, KL, CL-F, TRR), infectious diseases (BJAR, MB, TC, CJC, OAC, DRG, NAFJ, BJK, OL, MH-N, TFP, FLvdV), intensive care medicine (EA, SB, PD, PW-LL, IM-L, JAS, LV, JW), clinical pharmacology (RJMB, RL, IS), public health (TC) and hematology (OAC, JM)."}

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T39","span":{"begin":287,"end":299},"obj":"CHEBI:52217;CHEBI:52217"},{"id":"T68350","span":{"begin":287,"end":299},"obj":"CHEBI:52217;CHEBI:52217"}],"text":"To ensure heterogenicity, participants were selected from various fields of expertise: medical microbiology (PEV, KL, CL-F, TRR), infectious diseases (BJAR, MB, TC, CJC, OAC, DRG, NAFJ, BJK, OL, MH-N, TFP, FLvdV), intensive care medicine (EA, SB, PD, PW-LL, IM-L, JAS, LV, JW), clinical pharmacology (RJMB, RL, IS), public health (TC) and hematology (OAC, JM)."}